 |
 |
 |
|
Regenerate: a phase 3, double-blind, randomized, placebo-controlled
multicenter study of obeticholic acid therapy for nonalcoholic steatohepatitis
|
|
|
Reported by Jules Levin
EASL Conference: NASH Beyond the Acronym,
Certainties and Clinical Dilemmas 2016,
May 12-14 2016, Riga, Latvia









|
|
|
 |
 |
|
|